Pinney Associates, Inc. Celebrates 20th Anniversary
PR Newswire Association LLC |
"I am proud of our many successes and our ongoing commitment to furthering public health," said
PinneyAssociates serves the consumer healthcare and pharmaceutical industries, including innovator research and discovery companies, and manufacturers and distributors of branded and generic drug products.
Throughout the years, PinneyAssociates and its leadership have made significant contributions to public health and health policy. We continue to be a leader in:
- Promoting the value of Rx-to-OTC switches, direct-to-OTC approvals, and approved OTC products. Led by
Saul Shiffman , PhD, andLucy Owen our experts provide comprehensive support throughout the product lifecycle including counsel on labeling, consumer behavior research, and post-marketing support. - Promoting a deeper understanding of the complexities of pharmaceutical risk management for psychoactive medicines. Under the guidance of
Sidney Schnoll , MD, PhD, we provide advice on the most appropriate risk management path to enhance product safety and marketability through premarketing risk assessment of the scientific and policy environment. This includes support implementation and evaluation of risk management programs and Risk Evaluation and Mitigation Strategies (REMS) for individual compounds and formulations, and class-wide REMS. - Advancing the science of in vitro assessment of abuse-deterrent drugs and formulations ("tamper testing") and drug abuse potential assessment. Under the leadership of
Edward Cone , PhD, andJack Henningfield , PhD, our experts provide strategic advice and other support related to assessment of tamper-deterrent medications and abuse liability assessments within the context of scheduling and labeling regulations. - Expansion of tobacco dependence treatment availability, raising awareness of the challenges in promoting "reduced risk" tobacco and nicotine products, and promoting thoughtful and balanced approaches to tobacco harm minimization. Led by
Joe Gitchell andSaul Shiffman , PhD, we address tobacco and public health issues with the federal government, academia, health voluntary organizations, and as consultants to the private sector with the goal of minimizing, and eventually eliminating, the harm caused by the use of tobacco products.
In 1994, the company was launched with five employees. Today, our clients know they can rely on our 25 scientists, policy experts, researchers, analysts, and support staff.
"After 20 years, our clients continue to rely on the high-quality client service we provide and the strategic solutions we develop to successfully address regulatory, scientific, and health policy challenges," said
PinneyAssociates' senior leadership includes internationally respected leaders at the intersection of public health, behavioral science, and the development and marketing of medicines. We help our clients to manage issues and enhance the scientific and policy environments to gain regulatory approval of, and maximize acceptance of, consumer healthcare and pharmaceutical products.
For more information, please visit www.pinneyassociates.com or call +1 301-718-8440.
Logo - http://photos.prnewswire.com/prnh/20140218/NE67404LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pinney-associates-inc-celebrates-20th-anniversary-156717385.html
SOURCE
Wordcount: | 559 |
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News